Phase I and II clinical trials for gastric cancer

Nikhil I Khushalani1

  • 1Roswell Park Cancer Institute, Department of Medicine, Elm and Carlton Streets, Buffalo, NY 14263, USA. nikhil.khushalani@roswellpark.org

Insights

Gastric cancer is a heterogeneous global health issue. Personalized medicine combining targeted therapies with traditional treatments and targeting multiple pathways is crucial for overcoming resistance and improving patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Public Health

Background:

  • Gastric cancer presents significant global health challenges due to its diverse pathogenesis and clinical variability.
  • Advances in molecular biology offer new opportunities for targeted therapies in gastric cancer management.

Purpose of the Study:

  • To highlight the need for individualized treatment approaches in gastric cancer.
  • To emphasize strategies for overcoming therapeutic resistance through combination therapies and multi-pathway targeting.

Main Methods:

  • Review of current understanding of gastric cancer molecular biology.
  • Analysis of therapeutic resistance mechanisms.
  • Discussion of emerging treatment strategies.

Main Results:

  • Gastric cancer exhibits significant geographic heterogeneity in its molecular underpinnings and clinical manifestations.
  • Targeted interventions show promise but require integration with conventional therapies.
  • Overcoming resistance necessitates combination strategies and targeting multiple carcinogenic pathways.

Conclusions:

  • An individualized, molecularly informed approach is essential for effective gastric cancer management.
  • Future research should focus on biomarker-driven clinical trials to enhance patient outcomes.
  • Addressing therapeutic nihilism in gastric cancer requires innovative, multi-faceted treatment strategies.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...